...
首页> 外文期刊>Bulletin of experimental biology and medicine >Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age
【24h】

Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age

机译:基质金属蛋白酶MMP-1和MMP-9及其抑制剂TIMP-1作为不同年龄患者扩张心肌病的标志物

获取原文
获取原文并翻译 | 示例

摘要

We studied the expression of MMP-2, MMP-9, and inhibitor TIMP-1 in myocardial autopsy samples from subjects of different age and in cardiomyocyte cultures in the norm and in dilated cardiomyopathy. In autopsy samples of normal myocardium and in cardiomyocyte cultures, expression of molecules involved in extracellular matrix remodeling did not change during aging. In dilation cardiomyopathy, expression of MMP-2, MMP-9, and TIMP-1 and their ratios in autopsy material and in cultures was elevated by 1.5-9 times. Remodeling of extracellular matrix plays an important role in the pathogenesis of dilated cardiomyopathy. MMP-2, MMP-9, and their inhibitor TIMP-1 and the MMP/TIMP ratios can be regarded as promising predictors of dilated cardiomyopathy and used for evaluation of the effectiveness of treatment of this conditions in patients of different ages.
机译:我们研究了来自不同年龄的受试者的MMP-2,MMP-9和抑制剂TIMP-1的表达,以及在规范中的基础和心肌细胞培养物中和扩张的心肌病。 在正常心肌和心肌细胞培养物的尸检样本中,在老化期间,涉及细胞外基质重塑的分子的表达并未改变。 在扩张心肌病,MMP-2,MMP-9和TIMP-1的表达及其在尸检材料和培养物中的比率升高1.5-9倍。 细胞外基质的重塑在扩张心肌病的发病机制中起重要作用。 MMP-2,MMP-9及其抑制剂TIMP-1和MMP / TIMP比率可以被认为是扩张心肌病的预测因子,用于评估不同年龄患者治疗这种病症的治疗的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号